FCGR2B and chronic inflammatory demyelinating polyradiculoneuropathy: Confirmation of previous murine studies came following IVIG infusion in chronic inflammatory demyelinating polyneuropathy (CIDP) patients, which led to increased surface expression of FcγRIIB (68, 69).